The pill formulation of zanubrutinib (Brukinsa; BeOne) has become authorized for all five indications throughout many hematological cancers.Blood clots and encephalitis have also been claimed, and Regardless of no circumstances currently being noted as of but, There exists a potential threat of blood cancer, spurring gurus to endorse lifelong check